TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36481177

Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 93

Group type: COMPARATOR
Intervention: Sham Reiki
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control
Number of subjects: 93
Study: 33159496

Group type: EXPERIMENTAL
Intervention: Peginterferon alpha2b
Number of subjects: 114
Study: 34016663

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation with food rations (750 kcal and 23 g proteins/day) and multivitamins for HHC
Number of subjects: 11200

Group type: COMPARATOR
Intervention: Usual diet for HHC
Number of subjects: 11200

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (monthly food rations supplying 1200 kcal and 52 g proteins/day) and multivitamins along with antitubercular treatment for patients
Number of subjects: 11200

Group type: EXPERIMENTAL
Intervention: Nutritional assessment and counselling for both arms
Number of subjects: 11200

Group type: EXPERIMENTAL
Intervention: Substudies examining micronutrient status and effects on dietary intake, body composition, muscle strength and immune function
Number of subjects: 11200
Study: 33487438

Group type: EXPERIMENTAL
Intervention: Food monitoring
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: Permanent monitoring with real-time physician-generated feedback
Number of subjects: 1010

Group type: COMPARATOR
Intervention: Public-sector data handling
Number of subjects: 1010
Study: 35994789

Group type: EXPERIMENTAL
Intervention: Nedaplatin 30 mg/m2
Number of subjects: 160

Group type: COMPARATOR
Intervention: Cisplatin 40 mg/m2
Number of subjects: 160
Study: 32672806

Group type: EXPERIMENTAL
Intervention: Multimedia educational intervention (video and booklet)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 186
Study: 33082512

Group type: EXPERIMENTAL
Intervention: Prednisolone (2–2.5 mg/kg)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 33271891

Group type: EXPERIMENTAL
Intervention: Comprehensive interventions including nutrition education and physical activity
Number of subjects: 6764

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6764
Study: 35315706

Group type: EXPERIMENTAL
Intervention: Wii sports-based strategy training
Number of subjects: 192

Group type: COMPARATOR
Intervention: Traditional balance training (Control)
Number of subjects: 192
Study: 32184197

Group type: EXPERIMENTAL
Intervention: Toolkit intervention delivered to primary care practices
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pre-intervention data (control)
Number of subjects: 60
Study: 32171634

Group type: EXPERIMENTAL
Intervention: Boricua Youth Study wave 4 assessment
Number of subjects: 2491
Study: 35285811

Group type: EXPERIMENTAL
Intervention: Targeted Facebook campaign
Number of subjects: 386

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 386
Study: 35897006

Group type: EXPERIMENTAL
Intervention: rt‐PA + T group (low-dose rt-PA 0.6 mg/kg + tirofiban for 24 hours)
Number of subjects: 60

Group type: COMPARATOR
Intervention: rt‐PA group (standard dose rt-PA 0.9 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison of any ICH rates between rt‐PA + T and rt‐PA groups
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison of early neurological deterioration events (END) between rt‐PA + T and rt‐PA groups
Number of subjects: 60
Study: 33482030

Group type: EXPERIMENTAL
Intervention: Ultraviolet radiation (UV) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sulphuric acid-based fertilizer (SA) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35366831

Group type: EXPERIMENTAL
Intervention: Modified FOLFOXIRI or modified FOLFOX6 for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation and scheduled follow-up computed tomography scans
Number of subjects: 0
Study: 32959431

Group type: EXPERIMENTAL
Intervention: Virtual screen‐based stress management programme (V‐DESSERTS), individual‐based, twice‐daily sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlisted control group (WL)
Number of subjects: 0
Study: 32186326

Group type: EXPERIMENTAL
Intervention: Healthy low-carbohydrate diet
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Healthy low-fat diet
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 49
Study: 35312379

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram based on multiparametric MRI (mpMRI)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Calibration curve of the radiomics nomogram
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Decision curve analysis
Number of subjects: 233
Study: 33140499

Group type: EXPERIMENTAL
Intervention: Group-based motor and cognitive combined intervention (8-week program, group exercise and cognitive stimulation, twice per week for 45 min)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Group-based motor and cognitive combined intervention
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 31
Study: 33561623

Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Capsaicin (early administration)
Number of subjects: 55

Group type: COMPARATOR
Intervention: No Capsaicin
Number of subjects: 55
Study: 32185634

Group type: EXPERIMENTAL
Intervention: Kedo‐SG Blue (rotary file system)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Kedo‐S (paediatric rotary files)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Kedo‐SH (paediatric hand files)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hand K‐files (control group)
Number of subjects: 60
Study: 35788774

Group type: EXPERIMENTAL
Intervention: Lymph Node Ratio (LNR) ≤ 0.41
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Lymph Node Ratio (LNR)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Short interval between radiotherapy and surgery
Number of subjects: 141

Group type: COMPARATOR
Intervention: Long interval between radiotherapy and surgery
Number of subjects: 141
Study: 34528317

Group type: EXPERIMENTAL
Intervention: Yoga intervention (individual yoga practices at home, 10 weeks duration)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no yoga intervention)
Number of subjects: 160
Study: 34881930

Group type: EXPERIMENTAL
Intervention: Guided self-help cognitive-behavioral therapy (3 months)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 222
Study: 34819115

Group type: EXPERIMENTAL
Intervention: Daily healthy behavior text messaging and weekly self-measured blood pressure monitoring
Number of subjects: 0
Study: 32036701

Group type: EXPERIMENTAL
Intervention: Exposure to a friend's suicide
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Close friends with the person who died
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Peripheral friends
Number of subjects: 18
Study: 34856038

Group type: EXPERIMENTAL
Intervention: Guedes‐Pinto paste (GP)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Calcium Hydroxide and iodoform paste (CaOH/Iodof; Vitapex®)
Number of subjects: 61
Study: 32028393

Group type: EXPERIMENTAL
Intervention: Duloxetine (2 × 40 mg daily) + Pelvic Floor Muscle Training (PFMT) for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Duloxetine (2 × 40 mg daily)
Number of subjects: 0
Study: 35836478

Group type: EXPERIMENTAL
Intervention: Koji amazake (118 g/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Koji amazake
Number of subjects: 60
Study: 36266133

Group type: EXPERIMENTAL
Intervention: AERO intervention (tailored exercise adherence strategies based on a brief behavioural assessment plus standard physiotherapy)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual care (standard physiotherapy only)
Number of subjects: 48
Study: 34611065

Group type: EXPERIMENTAL
Intervention: A‐PRF + hyaluronic acid (HA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: A‐PRF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium chloride 0.9% (control)
Number of subjects: 0
Study: 32319204

Group type: EXPERIMENTAL
Intervention: Low-dose milk protein (pasteurized milk and milk protein powder)
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: High-dose milk protein (condensed milk)
Number of subjects: 485

Group type: COMPARATOR
Intervention: Negative double-blind placebo-controlled food challenge tests
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Symptoms during introduction
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Pasteurized milk as test material
Number of subjects: 485
Study: 35833564

Group type: EXPERIMENTAL
Intervention: CP/BPO 1.2%/3.75% gel
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: tretinoin 0.05% lotion
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: tazarotene 0.045% lotion
Number of subjects: 495
Study: 34865392

Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) model based on 7 optimal features in arterial phase (AP)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Random Forest model based on 14 optimal features in portal venous phase (PP)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Decision Tree model based on 7 optimal features in AP
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Extreme Gradient Boosting model based on 7 optimal features in AP
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Generalized Linear Model based on 7 optimal features in AP
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Neural Network model based on 7 optimal features in AP
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Decision Tree model based on 14 optimal features in PP
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Extreme Gradient Boosting model based on 14 optimal features in PP
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Generalized Linear Model based on 14 optimal features in PP
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Neural Network model based on 14 optimal features in PP
Number of subjects: 148
Study: 35302197

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonated Ringer's solution
Number of subjects: 96
Study: 32488427

Group type: EXPERIMENTAL
Intervention: Trazodone ER formulation (300 mg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Originator Trittico XR (300 mg)
Number of subjects: 44
Study: 33871023

Group type: EXPERIMENTAL
Intervention: Shower group (n=26)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Non-shower group (n=25)
Number of subjects: 51
Study: 35921451

Group type: EXPERIMENTAL
Intervention: Prasinezumab 1500 mg
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Prasinezumab 4500 mg
Number of subjects: 316

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 316

Group type: COMPARATOR
Intervention: Dopamine transporter levels (SPECT)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Serious adverse events
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Infusion reactions
Number of subjects: 316
Study: 34654180

Group type: EXPERIMENTAL
Intervention: Static (quenched) disorder in oscillator positions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomly moving oscillators (ballistically or diffusively)
Number of subjects: 0
Study: 33122738

Group type: EXPERIMENTAL
Intervention: Proximity extension assay measuring ST2, interleukin‐6, pentraxin‐3, interleukin‐10, renin, and myoglobin
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Proximity extension assay measuring TNF‐related apoptosis‐inducing ligand, TNF‐related activation induced cytokine, interleukin‐16, and cystatin B
Number of subjects: 131
Study: 36322332

Group type: COMPARATOR
Intervention: Placebo (ZOE-50)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo (ZOE-70)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo (ZOE-HSCT)
Number of subjects: 280
Study: 32794259

Group type: EXPERIMENTAL
Intervention: 0.3 mg aldafermin
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: 1 mg aldafermin
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: 3 mg aldafermin
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: 6 mg aldafermin
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 32891140

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 28
Study: 34521108

Group type: EXPERIMENTAL
Intervention: Id-KLH vaccine
Number of subjects: 36

Group type: COMPARATOR
Intervention: KLH only
Number of subjects: 36
Study: 32026838

Group type: EXPERIMENTAL
Intervention: Spinal manipulation and myofascial release (SMMRG)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Spinal manipulation alone (SMG)
Number of subjects: 72
Study: 35701639

Group type: EXPERIMENTAL
Intervention: CTG + FBS
Number of subjects: 1013

Group type: COMPARATOR
Intervention: CTG + STAN
Number of subjects: 1013
Study: 33518380

Group type: EXPERIMENTAL
Intervention: E-learning narrative intervention group
Number of subjects: 39

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 39
Study: 32399632

Group type: COMPARATOR
Intervention: Placebo arm of a smoking cessation study
Number of subjects: 130
Study: 35177153

Group type: EXPERIMENTAL
Intervention: Mobile-based brief intervention (BI)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Face-to-face brief intervention (BI)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Active control (information leaflet)
Number of subjects: 74
Study: 34548085

Group type: EXPERIMENTAL
Intervention: High-frequency augmented feedback (AF) group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Faded augmented feedback (AF) group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no AF)
Number of subjects: 30
Study: 32948200

Group type: COMPARATOR
Intervention: Platelet Rich Plasma (PRGF®)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 100 × 106 cultured autologous bone marrow mesenchymal stromal cells (BM‐MSCs) plus PRGF®
Number of subjects: 60
Study: 32993385

Group type: EXPERIMENTAL
Intervention: Speech disfluencies per 100 words and 100 syllables in children aged 6-9 years
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Criterion <3 stuttering-like disfluencies (SLD) per 100 syllables
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Criterion <3 SLD per 100 words
Number of subjects: 54
Study: 32404646

Group type: EXPERIMENTAL
Intervention: Lu-177 tin colloid
Number of subjects: 57

Group type: COMPARATOR
Intervention: Re-188 tin colloid
Number of subjects: 57
Study: 37843475

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided erector spinae plane block (ESPB)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 46
Study: 33247306

Group type: EXPERIMENTAL
Intervention: HP-TDR (high-protein total diet replacement)
Number of subjects: 43

Group type: COMPARATOR
Intervention: CON (control diet)
Number of subjects: 43
Study: 35314471

Group type: EXPERIMENTAL
Intervention: iCT-PTSD-YP
Number of subjects: 34

Group type: COMPARATOR
Intervention: Waiting List (WL)
Number of subjects: 34
Study: 33825070

Group type: EXPERIMENTAL
Intervention: PA + Charity (N=26; Fitbit, step goal, electronic weekly newsletter + charity donation if step goal achieved)
Number of subjects: 51

Group type: COMPARATOR
Intervention: PA (N=25; Fitbit, step goal, electronic weekly newsletter)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: PA + Charity
Number of subjects: 51
Study: 35946244

Group type: EXPERIMENTAL
Intervention: MTA (Mineral Trioxide Aggregate; Proroot Dentsply/Tulsa) with smear layer
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CEM (Calcium‐Enriched Mixture; Bionique Dent, Tehran) with smear layer
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ERRM (EndoSequence® Root Repair Material; Brasseler USA, Savannah, GA) with smear layer
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ERRM without smear layer
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CEM without smear layer
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MTA without smear layer
Number of subjects: 60
Study: 33595936

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cryotherapy combined with TENS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study: 35205004

Group type: EXPERIMENTAL
Intervention: Family Nurture Intervention (FNI)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 72
Study: 32291620

Group type: EXPERIMENTAL
Intervention: Furosemide/albumin
Number of subjects: 49

Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 49
Study: 34562750

Group type: EXPERIMENTAL
Intervention: Lenvatinib 14 mg/m2
Number of subjects: 31
Study: 32545062

Group type: EXPERIMENTAL
Intervention: Moringa oleifera (MO) leaf extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iron tablets
Number of subjects: 0
Study: 34762764

Group type: EXPERIMENTAL
Intervention: Educational intervention (1-hour discussion among staff using audit and feedback data)
Number of subjects: 4935

Group type: COMPARATOR
Intervention: Control (standard practice without the educational intervention)
Number of subjects: 4935
Study: 32194164

Group type: EXPERIMENTAL
Intervention: Wavelet phase coherence analysis of cerebral oxyhemoglobin (HbO2) in frequency interval III (0.05–0.15 Hz)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Predictive method using neuron‐specific enolase (NSE) and interval III value
Number of subjects: 83
Study: 35316569

Group type: EXPERIMENTAL
Intervention: Thrombosis events (TE) during therapy for ALL
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: Age and non-O blood group as independent predictors of TE
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: Induction TE
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: Thromboprophylaxis recommendation
Number of subjects: 794
Study: 33034409

Group type: EXPERIMENTAL
Intervention: RNP stage
Number of subjects: 2374

Group type: EXPERIMENTAL
Intervention: RNP stage and TRNPM staging system
Number of subjects: 2374

Group type: EXPERIMENTAL
Intervention: Nomograms
Number of subjects: 2374
Study: 37384061

Group type: EXPERIMENTAL
Intervention: Oral metronomic adjuvant chemotherapy (MAC) consisting of weekly methotrexate (15 mg/m2) and celecoxib (200 mg PO BD) for 18 months
Number of subjects: 137

Group type: COMPARATOR
Intervention: Observation post-complete response
Number of subjects: 137
Study: 33509019

Group type: EXPERIMENTAL
Intervention: Breviscapine (120 mg daily for 14 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 34649982

Group type: EXPERIMENTAL
Intervention: High-dose CIMT
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Moderate-dose CIMT
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual Customary Treatment (UCT)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: All CIMT groups
Number of subjects: 118
Study: 32596367

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (placebo treatment)
Number of subjects: 26
Study: 33527884

Group type: EXPERIMENTAL
Intervention: Hypnotherapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard stroke unit care
Number of subjects: 68
Study: 32597565

Group type: EXPERIMENTAL
Intervention: NBD regimen (sequential nephron blockade with diuretics)
Number of subjects: 140

Group type: COMPARATOR
Intervention: RASB regimen (sequential renin-angiotensin system blockade)
Number of subjects: 140
Study: 32930610

Group type: EXPERIMENTAL
Intervention: Collaborative Life Skills (CLS) program
Number of subjects: 159

Group type: COMPARATOR
Intervention: Usual services
Number of subjects: 159
Study: 33551347

Group type: EXPERIMENTAL
Intervention: ACLA group (colloidal bismuth pectin 200 mg thrice a day, lansoprazole 30 mg twice a day, amoxicillin 1 g twice a day, antofloxacin 200 mg once a day)
Number of subjects: 290

Group type: COMPARATOR
Intervention: LCLA group (levofloxacin 500 mg once a day)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: ACLA group (with antofloxacin susceptible strains)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: ACLA group (with antofloxacin resistant strains)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: LCLA group (with levofloxacin susceptible strains)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: LCLA group (with levofloxacin resistant strains)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: ACLA group
Number of subjects: 290

Group type: COMPARATOR
Intervention: LCLA group
Number of subjects: 290
Study: 35920037

Group type: EXPERIMENTAL
Intervention: High cotinine levels in smokers with brain aneurysm
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Smoking status
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Cotinine levels
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 86
Study: 34102583

Group type: COMPARATOR
Intervention: TV ad
Number of subjects: 7985

Group type: EXPERIMENTAL
Intervention: TV ad + Keep count of your drinks PBS
Number of subjects: 7985
Study: 32546648

Group type: EXPERIMENTAL
Intervention: Tamoxifen (5 years) / Goserelin (3 years)
Number of subjects: 488

Group type: COMPARATOR
Intervention: Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) (6 cycles)
Number of subjects: 488
Study: 33715300

Group type: EXPERIMENTAL
Intervention: Intervention Group 1 (IG1) - education by trained peer educators
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intervention Group 2 (IG2) - education by a health practitioner
Number of subjects: 90

Group type: COMPARATOR
Intervention: Comparison Group (CG) - no specific intervention mentioned
Number of subjects: 90
Study: 32710602

Group type: EXPERIMENTAL
Intervention: Global longitudinal strain (GLS)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: GLS below −10 cm/s
Number of subjects: 70

Group type: COMPARATOR
Intervention: GLS above −10 cm/s
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: GLS ≥ 17 cm/s
Number of subjects: 70